InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Chyung Yung H.. Officer active across 3 companies, notably Scholar Rock Holding Corp. Aggregated, 4 disclosures have been published. Activity tracked since 18 January 2022. The latest transaction was disclosed on 18 February 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 条申报中的 4 条
CHYUNG YUNG H. is an insider and Chief Medical Officer at Scholar Rock Holding Corp, Keros Therapeutics, Inc. and Tourmaline Bio, Inc. The declarant has 5 filings in total, and across the sampled recent filings from 2022-01-19 to 2025-02-19, the modal transaction nature is Attribution, with sum_buy_eur at 0 and sum_sell_eur at 0.